doi: 10.1038/nm.4131.
A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation
Affiliations
- PMID: 27387881
- PMCID: PMC7096003
- DOI: 10.1038/nm.4131
Item in Clipboard
A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation
Nat Med.
.
Abstract
As part of the World Health Organization (WHO) R&D Blueprint initiative, leading stakeholders on Middle East respiratory syndrome coronavirus (MERS-CoV) convened to agree on strategic public-health goals and global priority research activities that are needed to combat MERS-CoV.
Supplementary information: The online version of this article (doi:10.1038/nm.4131) contains supplementary material, which is available to authorized users.
Conflict of interest statement
X.W. has a patent pending regarding peptides inhibiting TDP-43 mitochondrial localization.
Similar articles
-
Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Infection, Immunological Response, and Vaccine Development.J Immunol Res. 2019 Apr 7;2019:6491738. doi: 10.1155/2019/6491738. eCollection 2019. J Immunol Res. 2019. PMID: 31089478 Free PMC article. Review.
-
Evaluation of Patients under Investigation for MERS-CoV Infection, United States, January 2013-October 2014.Emerg Infect Dis. 2015 Jul;21(7):1220-3. doi: 10.3201/eid2107.141888. Emerg Infect Dis. 2015. PMID: 26079433 Free PMC article.
-
Performance and clinical validation of the RealStar MERS-CoV Kit for detection of Middle East respiratory syndrome coronavirus RNA.J Clin Virol. 2014 Jun;60(2):168-71. doi: 10.1016/j.jcv.2014.03.012. Epub 2014 Mar 28. J Clin Virol. 2014. PMID: 24726679 Free PMC article.
-
Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain.Viruses. 2019 Jan 14;11(1):60. doi: 10.3390/v11010060. Viruses. 2019. PMID: 30646569 Free PMC article. Review.
-
MERS-CoV spike protein: Targets for vaccines and therapeutics.Antiviral Res. 2016 Sep;133:165-77. doi: 10.1016/j.antiviral.2016.07.015. Epub 2016 Jul 26. Antiviral Res. 2016. PMID: 27468951 Free PMC article. Review.
Cited by
-
Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine.Cell Rep Med. 2022 Jul 19;3(7):100685. doi: 10.1016/j.xcrm.2022.100685. Cell Rep Med. 2022. PMID: 35858586 Free PMC article.
-
MERS: Progress on the global response, remaining challenges and the way forward.Antiviral Res. 2018 Nov;159:35-44. doi: 10.1016/j.antiviral.2018.09.002. Epub 2018 Sep 17. Antiviral Res. 2018. PMID: 30236531 Free PMC article. Review.
-
Outbreak response as an essential component of vaccine development.Lancet Infect Dis. 2019 Nov;19(11):e399-e403. doi: 10.1016/S1473-3099(19)30305-6. Epub 2019 Jun 27. Lancet Infect Dis. 2019. PMID: 31256955 Free PMC article. Review.
-
Diagnostics for Lassa fever virus: a genetically diverse pathogen found in low-resource settings.BMJ Glob Health. 2019 Feb 7;4(Suppl 2):e001116. doi: 10.1136/bmjgh-2018-001116. eCollection 2019. BMJ Glob Health. 2019. PMID: 30899575 Free PMC article.
-
Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus.Emerg Microbes Infect. 2018 Apr 4;7(1):60. doi: 10.1038/s41426-018-0056-7. Emerg Microbes Infect. 2018. PMID: 29618723 Free PMC article.
References
-
- WHO. http://www.who.int/csr/disease/coronavirus_infections/MERS-CoV_summary_u... (World Health Organization, Geneva, 2014).
-
- Cohen J. Science. 2016;351:16–19. - PubMed
-
- Ben Embarek PK, Van Kerkhove MD. Wkly. Epidemiol. Rec. 2015;90:245–250. - PubMed
-
- Drosten C, et al. Clin. Infect. Dis. 2015;60:369–377. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
